Triumeq PD is a Kit in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is .
| Product ID | 49702-258_7270d03e-4afd-4242-a4bf-ff14f79fc16c |
| NDC | 49702-258 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Triumeq PD |
| Generic Name | Abacavir Sulfate, Dolutegravir Sodium, Lamivudine |
| Dosage Form | Kit |
| Marketing Start Date | 2022-03-30 |
| Marketing Category | NDA / |
| Application Number | NDA215413 |
| Labeler Name | ViiV Healthcare Company |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-03-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 49702-258 | Triumeq PD | abacavir sulfate, dolutegravir sodium, lamivudine |
| 49702-231 | Triumeq | abacavir sulfate, dolutegravir sodium, lamivudine |
| 50090-1606 | Triumeq | abacavir sulfate, dolutegravir sodium, lamivudine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TRIUMEQ PD 90032640 not registered Live/Pending |
ViiV Healthcare Company 2020-07-02 |